Healthcare - Biotechnology - NASDAQ - US
$ 3.61
2.27 %
$ 28.3 M
Market Cap
-6.94
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--3.10%
EBIT
Estimate
--9.17%
Net Income
Estimate
--89.23%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ImmuCell Corporation
ICCC has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ICCC
EBIT FORECAST
EBIT Forecast Chart ICCC
NET INCOME FORECAST
Net Income Chart ICCC